Hunter M G, Avalos B R
Molecular, Cellular, and Developmental Biology Program, Bone Marrow Transplantation Program, The Ohio State University, Arthur G. James Cancer Hospital and Research Institute, Columbus, OH 43210, USA.
Blood. 1999 Jan 15;93(2):440-6.
Acquired mutations in the granulocyte colony-stimulating factor receptor (G-CSFR) occur in a subset of patients with severe congenital neutropenia (SCN) who develop acute myelogenous leukemia (AML). These mutations affect one allele and result in hyperproliferative responses to G-CSF, presumably through a dominant-negative mechanism. Here we show that a critical domain in the G-CSFR that mediates ligand internalization is deleted in mutant G-CSFR forms from patients with SCN/AML. Deletion of this domain results in impaired ligand internalization, defective receptor downmodulation, and enhanced growth signaling. These results explain the molecular basis for G-CSFR mutations in the pathogenesis of the dominant-negative phenotype and hypersensitivity to G-CSF in SCN/AML.
粒细胞集落刺激因子受体(G-CSFR)的获得性突变发生在一部分患有严重先天性中性粒细胞减少症(SCN)并发展为急性髓性白血病(AML)的患者中。这些突变影响一个等位基因,并可能通过显性负性机制导致对G-CSF的过度增殖反应。我们在此表明,SCN/AML患者的突变型G-CSFR形式中,介导配体内化的G-CSFR关键结构域缺失。该结构域的缺失导致配体内化受损、受体下调缺陷以及生长信号增强。这些结果解释了SCN/AML中显性负性表型发病机制及对G-CSF超敏反应中G-CSFR突变的分子基础。